Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn about how effective 2 chemotherapy drugs
carboplatin (Paraplatin) plus docetaxel (Taxotere) in the treatment of patients with
anaplastic prostate cancer. Patients who continue to have advanced disease will be switched
to etoposide (VePesid) plus cisplatin (Platinol-AQ) to study how effective this second line
of chemotherapy is in the treatment of patients iwth anaplastic prostate cancer.
The side effects, characteristics of patients who respond, and overall survival will also be
studied.